Search - tctmd.com

Displaying 581 - 600 of 842

Sort: Relevancy | Date

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

News Conference News TCT 2015

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

October 11, 2015

Presentation

Direct Comparison of VH-IVUS and OCT Imaging for Identification of Thin-Cap Fibroatheroma

Presenter: AJ. Brown

October 09, 2015

News Daily News

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

L.A. McKeown

September 28, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

L.A. McKeown

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

News Daily News

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation Aortovascular 2015

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Presenter: William A. Gray

September 18, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Daily News

急性心梗发作后的心脏康复与生存率改善、用药依从性相关

Leah Lawrence

August 30, 2015

News Daily News

La Rehabilitación Cardíaca Post-IAM se asoció a una Mejor Supervivencia y Adherencia a la Medicación

Leah Lawrence

August 30, 2015

News Daily News

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

Leah Lawrence

August 30, 2015

Presentation

Effectiveness of Cardiac Rehabilitation Among Older Patients after Acute MI

Presenter: Jacob A. Doll

August 27, 2015

Advertisement

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

Direct Comparison of VH-IVUS and OCT Imaging for Identification of Thin-Cap Fibroatheroma

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

急性心梗发作后的心脏康复与生存率改善、用药依从性相关

La Rehabilitación Cardíaca Post-IAM se asoció a una Mejor Supervivencia y Adherencia a la Medicación

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

Effectiveness of Cardiac Rehabilitation Among Older Patients after Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content